Myeloid toxicity in breast cancer patients receiving adjuvant chemotherapy with pegfilgrastim support

被引:17
|
作者
Wolff, AC [1 ]
Jones, RJ [1 ]
Davidson, NE [1 ]
Jeter, SC [1 ]
Stearns, V [1 ]
机构
[1] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA
关键词
D O I
10.1200/JCO.2006.05.7174
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2392 / 2394
页数:3
相关论文
共 50 条
  • [1] Myeloid toxicity in breast cancer patients receiving adjuvant chemotherapy with pegfilgrastim support - Reply
    Burstein, Harold J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (15) : 2394 - 2395
  • [2] Myeloid toxicity in breast cancer patients receiving adjuvant chemotherapy: What is the appropriate use of filgrastim?
    Ferretti, Gianluigi
    Lopez, Massimo
    Terzoli, Edmondo
    Cortesi, Enrico
    Antimi, Mauro
    Marolla, Paolo
    Giannarelli, Diana
    Cognetti, Francesco
    Papaldo, Paola
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (35) : 5618 - +
  • [3] Neutrophil recovery in elderly breast cancer patients receiving adjuvant anthracycline-containing chemotherapy with pegfilgrastim support
    Brugger, W.
    Bacon, P.
    Lawrinson, S.
    Romieu, G.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2009, 72 (03) : 265 - 269
  • [4] Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy
    Arti Hurria
    Kelly Brogan
    Katherine S. Panageas
    Carol Pearce
    Larry Norton
    Ann Jakubowski
    Marjorie Zauderer
    Jane Howard
    Clifford Hudis
    Breast Cancer Research and Treatment, 2005, 92 : 151 - 156
  • [5] Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy
    Hurria, A
    Brogan, K
    Panageas, KS
    Pearce, C
    Norton, L
    Jakubowski, A
    Zauderer, M
    Howard, J
    Hudis, C
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 92 (02) : 151 - 156
  • [6] Empiric dose reduction of pegfilgrastim in breast cancer patients receiving cytotoxic chemotherapy
    Paba, C.
    Sachdev, J.
    Kronish, L.
    Jahanzeb, M.
    Waheed, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Toxicity of adjuvant chemotherapy in elderly breast cancer patients
    Rana, F.
    Garg, P.
    Guthrie, T.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (01) : 470 - 470
  • [8] Clinical Impact of Primary Prophylactic Pegfilgrastim in Breast Cancer Patients Receiving Adjuvant Docetaxel-Doxorubicin-Cyclophosphamide Chemotherapy
    Jeon, Ye Won
    Lim, Seung Taek
    Gwak, HongKi
    Park, Seon Young
    Suh, Young Jin
    JOURNAL OF BREAST CANCER, 2020, 23 (05) : 521 - 532
  • [9] Efficacy and Safety of Balugrastim Compared With Pegfilgrastim in Patients With Breast Cancer Receiving Chemotherapy
    Volovat, Constantin
    Gladkov, Oleg A.
    Bondarenko, Igor M.
    Barash, Steve
    Buchner, Anton
    Bias, Peter
    Adar, Liat
    Avisar, Noa
    CLINICAL BREAST CANCER, 2014, 14 (02) : 101 - 108
  • [10] Effect of Creatinine Clearance on Patterns of Toxicity in Older Patients Receiving Adjuvant Chemotherapy for Breast Cancer
    Arti Hurria
    Anju Hurria
    Kelly Brogan
    Katherine S. Panageas
    Carol Pearce
    Larry Norton
    Ann Jakubowski
    Jane Howard
    Clifford Hudis
    Drugs & Aging, 2005, 22 : 785 - 791